Baxter and ScinoPharm Partner to Develop Generic Oncology Injectables

Article

Baxter International and ScinoPharm Taiwan have teamed up in a strategic partnership to develop, manufacture, and commercialize generic oncology injectables, according to a press release.

Baxter International and ScinoPharm Taiwan have teamed up in a strategic partnership to develop, manufacture, and commercialize generic oncology injectables, according to a press release.

The partnership will include 5 injectable drugs used in a variety of cancer treatments, including lung cancer, multiple myeloma, and breast cancer, and allows Baxter the option to partner with ScinoPharm on up to 15 additional injectable molecules. Plans also call for the development of treatments for adverse effects that are associated with chemotherapy, such as nausea and vomiting.

Both companies will partner on the product development and manufacturing aspects of the injectables, and Baxter will hold commercialization rights.

Baxter’s multifaceted portfolio includes various generic injectable medications, including difficult-to-manufacture oncology drugs as well as standard-dose, ready-to-use premixed injectable products such as anti-infectives, analgesics, and critical care medicines. ScinoPharm is known for manufacturing APIs for the pharmaceutical industry, and will provide APIs for the initial 5 generic injectables slated for development.

“Combining Baxter’s differentiated manufacturing expertise and global commercialization capabilities with ScinoPharm’s recognized API experience enables Baxter to increase patient access to difficult-to-manufacture, high-quality oncolytic medicines,” Robert Felicelli, president, Pharmaceuticals, Baxter, said in a press release.

The 5 generic injectables are expected for launch beginning in 2020.

Related Videos
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz - stock.adobe.com
Image credit: New Africa | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Image Credit: Pixel-Shot | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.